Big 4 revenues up, profitability down

Published: 2009-11-03 07:00:00

Updated: 2009-11-03 07:00:00

The nation’s top four companies, such as Dong-A Pharm, Hanmi Pharm and Green Cross Corporation, saw their revenues increase on robust sales of flagship products in the third quarter of the year. But their ability to generate cash from a variety of operating activities fell on worsening profitabil...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK